A data-zone scoring system to assess the generalizability of clinical trial results

Luke Laffin, MD, cardiologist in the Section of Preventive Cardiology at Cleveland Clinic discusses his recently published paper with Stephanie Besser, MSA, MSPA, and Francis Alenghat, MD, PhD, from the University of Chicago which dove into the results of the SPRINT and ACCORD-BP trials to answer the question if trial results looking at a specific population of patients can apply to specific patients in clinic. The team developed a tool to answer this question.